CheckMyRecalls

Merck Sharp & Dohme LLC recalls Merck Emend (aprepitant) for oral…

Merck Sharp & Dohme LLC recalls Merck Emend (aprepitant) for oral suspension and 1 more

Published
31 Dec 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Presence of particulate matter: potential presence of metal particulates in the product.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03

Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.

Brand / company
Merck Sharp & Dohme LLC
Codes / lots
Lot #: Z014503, Exp 11/15/2027 | Lot#: Z012339, Z010344, Z009908, Z009909, Exp Date 12-31-2026
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 31 Dec 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.